Study guide

9.2 Risk Adjustment & Healthcare Severity Modeling

AHIMA Certified Health Data Analyst CHDA

Track your progress as you read

Finished sections get a check mark.

1 Introduction & CHDA Exam Overview

0.1 About the AHIMA CHDA Exam 0.2 How to Use This Study Guide

2 Chapter 1: Healthcare Delivery Systems & Revenue Cycle

1.1 Healthcare Delivery Settings & Organizational Structures 1.2 Healthcare Revenue Cycle Management & Reimbursement Models 1.3 Regulatory Reporting & Accreditation Agencies

3 Chapter 2: Health Informatics, Datasets & AI

2.1 Electronic Health Records (EHR) & Health Informatics Foundations 2.2 Healthcare Datasets, Benchmarks & Population Health 2.3 Analytics Hierarchy & Artificial Intelligence in Healthcare

4 Chapter 3: Clinical Terminologies, Classifications & Standards

3.1 Clinical Classification Systems: ICD-10-CM/PCS & CPT/HCPCS 3.2 Clinical Terminologies & Ontologies: SNOMED CT, LOINC & RxNorm 3.3 Interoperability & Data Exchange Standards: HL7 v2, CDA & FHIR

5 Chapter 4: Business Needs Assessment & Scoping

4.1 Stakeholder Engagement & Analytics Needs Elicitation 4.2 Defining Metrics, KPIs & Healthcare Value 4.3 Analytics Project Management & Analysis Planning

6 Chapter 5: Data Sourcing, Lineage & Collection Methods

5.1 Healthcare Data Sourcing & Lineage 5.2 Healthcare Data Collection Methods & Architectures 5.3 Clinical & Financial Data Extraction

7 Chapter 6: Data Cleansing, Transformation & Validation

6.1 Healthcare Data Quality Assessment 6.2 Data Cleansing & Anomaly Remediation 6.3 Data Transformation, Mapping & Validation

8 Chapter 7: Exploratory Data Analysis & Descriptive Statistics

7.1 Healthcare Data Types & Scales of Measurement 7.2 Measures of Central Tendency & Dispersion 7.3 Exploratory Data Analysis in Clinical Populations

9 Chapter 8: Inferential Statistics & Hypothesis Testing

8.1 Sampling Techniques & Probability in Healthcare 8.2 Hypothesis Testing Fundamentals 8.3 Parametric vs. Non-Parametric Tests

10 Chapter 9: Advanced Statistical Modeling & Risk Adjustment

9.1 Correlation & Regression Analysis 9.2 Risk Adjustment & Healthcare Severity Modeling 9.3 Survival Analysis & Model Evaluation

11 Chapter 10: Healthcare Epidemiology & Study Methodologies

10.1 Epidemiological Measures of Disease Frequency & Association 10.2 Healthcare Study Designs & Methodologies 10.3 Confounding, Bias & Health Equity Analytics

12 Chapter 11: Healthcare Data Visualization & Dashboard Design

11.1 Principles of Effective Healthcare Data Visualization 11.2 Selecting Appropriate Healthcare Visualizations 11.3 Executive & Clinical Dashboard Architecture

13 Chapter 12: Healthcare Performance Measurement & CMS Quality Programs

12.1 CMS Quality Programs & Value-Based Purchasing 12.2 Clinical Quality Measures & Benchmarking 12.3 Financial Analytics & Case Mix Index Analysis

14 Chapter 13: Communicating Insights & Narrative Analytics

13.1 Translating Complex Analytics for Diverse Audiences 13.2 Contextualizing Limitations, Assumptions & Uncertainty 13.3 Narrative Reporting & Data-Driven Decision Support

15 Chapter 14: Healthcare Data Governance Frameworks & Stewardship

14.1 Enterprise Data Governance Frameworks 14.2 Data Stewardship & Master Patient Index (MPI) Management 14.3 Metadata Management & Business Glossaries

16 Chapter 15: Healthcare Privacy, Security & Data Ethics

15.1 HIPAA Privacy & Security Rules for Analysts 15.2 De-Identification Methodologies 15.3 Data Ethics, Audit Trails & Secondary Data Use

9.2 Risk Adjustment & Healthcare Severity Modeling

Key Takeaways Explain This Topic AI

Risk adjustment supports fairer comparison by accounting for measured differences in patient characteristics, but it cannot remove unmeasured confounding or repair poor source data.

For Medicare Advantage payment year 2026, CMS uses the 2024 CMS-HCC risk-adjustment model (often called V28) at 100%; mappings, hierarchies, coefficients, normalization, and model segments are version-specific.

A CMS-HCC score combines demographic terms, retained hierarchical condition categories, applicable interactions, and current CMS adjustments; analysts must use the official files for the payment year rather than memorize legacy HCC numbers or coefficients.

Hospital profiling may use hierarchical models in which a risk-standardized rate is calculated as predicted divided by expected outcomes, multiplied by the national observed rate; this is different from a simple observed-to-expected ratio.

Discrimination, calibration, validity, and fitness for the intended population must all be evaluated; no single metric establishes model quality.

Last updated: August 2026

Risk Adjustment & Healthcare Severity Modeling

Quick Answer: Risk adjustment estimates expected resource use or outcomes after accounting for measured patient differences. It makes comparisons more defensible, but it does not make unlike populations identical. For Medicare Advantage payment year 2026, CMS uses the 2024 CMS-HCC model (V28) at 100% . Exact diagnosis mappings, HCC numbers, coefficients, interactions, normalization factors, and model segments are year-specific and must be taken from the applicable CMS files.

1. Why Risk Adjustment Is Needed

Raw outcomes mix at least three influences: patient risk, care processes, and random variation. A tertiary center treating transferred patients with advanced disease may have a higher crude mortality rate than a low-acuity community facility even if its care is excellent. Conversely, a low event rate can reflect favorable selection rather than better care.

A risk model attempts to estimate what would be expected given measured characteristics such as age, sex, diagnoses, prior utilization, functional status, or other permitted factors. The intended use determines which predictors are appropriate. Payment models, public outcome measures, and internal clinical prediction models have different estimands and exclusions.

Risk adjustment does not justify controlling away a disparity that the analysis is meant to expose. For an equity question, decide whether race, language, disability, or social risk is a confounder, a stratification variable, a mediator, or part of the outcome definition before modeling. Always report important unadjusted and stratified results alongside adjusted findings when they answer different questions.

2. The Current CMS-HCC Conceptual Workflow

CMS-HCC is a prospective risk-adjustment approach used in Medicare Advantage. In a simplified workflow:

Confirm the payment year, model segment, and official CMS model files.

Validate eligible diagnoses from permitted data sources and dates of service.

Map ICD-10-CM diagnoses to condition categories using the applicable mapping.

Apply disease hierarchies so a more severe related condition can supersede a less severe category where the model specifies.

Add demographic factors and any applicable disease or demographic interactions.

Apply the current model’s coefficients, normalization, and other CMS adjustments.

Validate reconciliation totals and investigate material changes from the prior model or year.

For payment year 2026, CMS completed the phase-in of the 2024 CMS-HCC model and uses it at 100%. Older V24 examples with familiar HCC numbers are not reliable proxies: categories were restructured and renumbered, mappings changed, and coefficients depend on model segment and year.

The generic structure is:

Risk score = demographic contribution + retained condition-category contributions + applicable interaction contributions

That expression is conceptual, not a production calculator. A hypothetical patient with a demographic contribution of 0.40, retained disease contributions of 0.31 and 0.18, and a permitted interaction of 0.07 would have an illustrative pre-adjustment sum of 0.96. Those numbers are invented for arithmetic practice; they are not CMS coefficients.

Hierarchies and interactions

A hierarchy prevents double-counting related levels of disease severity. If the current mapping places two conditions in one hierarchy, only the category specified by the hierarchy survives. Unrelated categories may remain additive. Interactions are separate model terms that capture combinations whose expected cost differs from the simple sum of their main effects.

Never infer the hierarchy from clinical intuition alone. Use the official software and mapping files. Also distinguish a condition documented in the chart from a diagnosis eligible for the particular risk-adjustment submission. Documentation, coding, data-source, and timing rules all matter.

3. Other Severity and Risk Systems

System Typical use Unit of analysis Important distinction

CMS-HCC Medicare Advantage payment risk Person/year or payment period Prospective, payment-specific, and versioned

MS-DRG Medicare inpatient prospective payment Inpatient stay Groups a stay by diagnoses, procedures, and severity logic

APR-DRG All-payer severity and mortality comparisons Inpatient stay Adds severity-of-illness and risk-of-mortality subclasses

Charlson-based methods Comorbidity adjustment in research Patient/encounter Implementations and weights vary; document the version

Elixhauser-based methods Comorbidity adjustment in outcomes research Patient/encounter Condition definitions and scoring approaches vary

CDPS Medicaid risk adjustment Person Developed around disability and Medicaid populations

ACG or similar grouping systems Population management and utilization prediction Person/population Proprietary specifications may apply

Do not substitute one system merely because both are called “risk adjustment.” A payment model may be unsuitable for estimating causal treatment effects. A stay-level severity grouper does not automatically provide a prospective annual cost score.

4. Observed-to-Expected Ratios

A simple observed-to-expected ratio is:

O/E = observed events / expected events

If 36 readmissions are observed and the validated model predicts 30, O/E = 36 / 30 = 1.20. The organization experienced 20% more events than expected under that model. If 24 are observed, O/E = 0.80, or 20% fewer than expected.

Interpretation requires uncertainty. An O/E above 1 is not automatically statistically distinguishable from 1, and “expected” is conditional on the model, data, and reference population. Report confidence intervals or another suitable uncertainty estimate, examine calibration, and check whether low volume makes the ratio unstable.

CMS hierarchical risk-standardized outcomes

Do not conflate simple O/E with every CMS measure. For several hospital outcome measures, CMS uses a hierarchical generalized linear model and reports a risk-standardized rate in this form:

Risk-standardized rate = (predicted outcomes / expected outcomes) × national observed rate

“Predicted” incorporates the hospital-specific effect for its patients; “expected” estimates outcomes for those same patients at an average hospital. Empirical Bayes shrinkage pulls unstable estimates from low-volume hospitals toward the overall mean. The current measure methodology must be consulted for exact cohorts, risk variables, time windows, and exclusions.

5. Validation and Governance

A model can discriminate well and still be poorly calibrated. Evaluate several dimensions:

Discrimination: Can the model rank higher-risk patients above lower-risk patients? For binary outcomes, ROC AUC is common.

Calibration: Do predicted probabilities agree with observed frequencies overall and across clinically meaningful risk ranges? Use calibration plots, calibration intercept/slope, and appropriate summaries.

Internal validity: Use resampling or cross-validation to estimate optimism.

External validity: Test performance in the target sites, populations, and time period.

Data validity: Confirm coding completeness, lookback windows, enrollment, duplicate handling, and mapping versions.

Fairness and transportability: Examine performance and error rates across relevant subgroups without assuming equal aggregate AUC means equal impact.

Change control: Version model files, mappings, code, input snapshots, approval records, and reconciliation outputs.

A non-significant goodness-of-fit test does not prove calibration, and an AUC threshold does not prove clinical utility. Model approval should tie performance to the intended decision and the harm of false positives and false negatives.

6. Practical Audit Checklist

Before releasing risk-adjusted results, ask:

What decision and estimand does the adjustment support?

Is the model current for the payment or measurement year?

Are the cohort, source, and lookback rules implemented exactly?

Were mappings, hierarchies, interactions, and model segments version-controlled?

Are observed, expected, and predicted quantities labeled correctly?

Were discrimination, calibration, uncertainty, and subgroup performance assessed?

Can another analyst reproduce the result from retained code and approved inputs?

The exam-relevant principle is durable: choose an approach that fits the question, explain it, validate it, and interpret the adjusted result without overstating what adjustment can accomplish.

Loading diagram... Version-Aware CMS-HCC Risk Score Workflow